Edwards Lifesciences Corporation Payments to Acquire Other Investments
Edwards Lifesciences Corporation (EW) reported Payments to Acquire Other Investments of $823.20 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2014-02-28
- Edwards Lifesciences Corporation payments to acquire other investments for the quarter ending 2013-12-31 was $449.30M, a 576.66% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire other investments for the quarter ending 2013-09-30 was $151.90M, a 45.67% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire other investments for the quarter ending 2013-06-30 was $129.30M, a 7.97% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire other investments for the quarter ending 2013-03-31 was $92.70M, a 12.63% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire other investments for fiscal 2013 was $823.20M, a 38.91% increase from fiscal 2012.
- Edwards Lifesciences Corporation payments to acquire other investments for fiscal 2012 was $592.60M, a 7.88% decline from fiscal 2011.
- Edwards Lifesciences Corporation payments to acquire other investments for fiscal 2011 was $643.30M.
| Period end | Payments to Acquire Other Investments 3 month | Payments to Acquire Other Investments 3 month as first filed | Payments to Acquire Other Investments 6 month | Payments to Acquire Other Investments 6 month as first filed | Payments to Acquire Other Investments 9 month | Payments to Acquire Other Investments 9 month as first filed | Payments to Acquire Other Investments 12 month |
|---|---|---|---|---|---|---|---|
| 2013-12-31 | $449.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $601.20M derived: sum of 2 quarters · filed 2014-02-28 | $730.50M derived: sum of 3 quarters · filed 2014-02-28 | $823.20M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $151.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $281.20M derived: sum of 2 quarters · filed 2013-11-07 | $373.90M 10-Q · filed 2013-11-07 | $440.30M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2013-06-30 | $129.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $222.00M 10-Q · filed 2013-08-06 | $288.40M derived: sum of 3 quarters · filed 2014-02-28 | $568.00M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2013-03-31 | $92.70M 10-Q · filed 2013-05-06 | $159.10M derived: sum of 2 quarters · filed 2014-02-28 | $438.70M derived: sum of 3 quarters · filed 2014-02-28 | $579.20M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-12-31 | $66.40M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $346.00M derived: sum of 2 quarters · filed 2014-02-28 | $486.50M derived: sum of 3 quarters · filed 2014-02-28 | $592.60M 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $279.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $420.10M derived: sum of 2 quarters · filed 2013-11-07 | $526.20M 10-Q · filed 2013-11-07 | $715.50M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-06-30 | $140.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $246.60M 10-Q · filed 2013-08-06 | $435.90M derived: sum of 3 quarters · filed 2014-02-28 | $585.60M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-03-31 | $106.10M 10-Q · filed 2013-05-06 | $295.40M derived: sum of 2 quarters · filed 2014-02-28 | $445.10M derived: sum of 3 quarters · filed 2014-02-28 | $643.80M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $189.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $339.00M derived: sum of 2 quarters · filed 2014-02-28 | $537.70M derived: sum of 3 quarters · filed 2014-02-28 | $643.30M 10-K · filed 2014-02-28 | |||
| 2011-09-30 | $149.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $348.40M derived: sum of 2 quarters · filed 2012-11-07 | $454.00M 10-Q · filed 2012-11-07 | -$454.00M 10-K · filed 2012-02-27 | |||
| 2011-06-30 | $198.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $304.30M 10-Q · filed 2012-08-07 | -$304.30M 10-K · filed 2012-02-27 | ||||
| 2011-03-31 | $105.60M 10-Q · filed 2012-08-07 | -$105.60M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |